In the early 1960s, Howorth’s experience and skills were applied in response to the needs of the medical profession. Working in close collaboration with renowned orthopaedic surgeon, Sir John Charnley, Howorth designed and developed the world’s first Ultra Clean Ventilation (UCV) system for operating theatres. From this pioneering first step, the company went on to create the Howorth Exflow™ UCV which, in its current derivation, remains a global leader in the field of ultra clean ventilation. In addition to the Exflow, Howorth also provides a broad range of additional products and services for the medical market, ranging from operating theatre lighting and ceiling service units to complete turnkey healthcare facilities. The Howorth Exflow™ UCV, as it is now known, remains a global leader in the field of ultra clean ventilation. As a supplier and partner to global biopharma companies for many years, we understand the increasingly onerous international health & safety standards that our clients are expected to meet. Howorth provides a full range of aseptic and containment barrier solutions developed specifically for the biopharmaceutical and pharmaceutical industry. Today, this expertise in engineering clean air is fundamental to our success in providing world class containment and infection control solutions, serving the global pharmaceutical and wider industrial markets; Process, Production, Pharma, Bio Technology, Contract Facilities. Recently there have been advancements made within the rapidly growing biotechnology industry which has resulted in an increased demand for new facilities that address their particular drivers and requirements. Howorth have the skills and experience to deal with these demanding markets together with a full appreciation of the equipment which populate facilities of this type.